3 completed, 1 recruiting. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Recruiting 1 |
Follow Cerebral Ischemia: new trials by email Literature Review of Cerebral Ischemia trials Research Report on Cerebral Ischemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Xenon on Brain Injury After Aneurysmal Subarachnoid Hemorrhage Xenon, air/oxygen - Subarachnoid Hemorrhage, Aneurysmal, Cerebral Injury | Phase 2 | Recruiting | Turku University Hospital | 160 | 2025-04-22 | 2025-05-01 |
| PMZ-1620 (Sovateltide) in Acute Ischemic Stroke Patients Normal Saline along with standard treatment, PMZ-1620 along with standard treatment - Acute Stroke, Cerebral Ischemia | Phase 2 | Completed | Pharmazz, Inc. | 40 | 2018-01-19 | 2025-05-12 |
| Safety and Feasibility of Argatroban, Tissue Plasminogen Activator and Intra-arterial Therapy in Stroke Argatroban - Stroke, Cerebral Ischemia | Phase 2 | Completed | The University of Texas Health Science Center, Houston | 10 | 2015-05-01 | 2017-06-21 |
| Safety and Effect of SANGUINATE⢠Infusion in Patients at Risk of Delayed Cerebral Ischemia (DCI) Following Subarachnoid Hemorrhage (SAH) SANGUINATE⢠- Cerebral Ischemia | Phase 2 | Completed | Prolong Pharmaceuticals | 12 | 2014-12-01 | 2016-10-27 |
Brain Ischemia (4) · Stroke (2) · Subarachnoid Hemorrhage (2) · Brain Injuries (1) · Cardiovascular Diseases (1) · Cerebral Infarction (1) · Heart Failure (1)
Brain Diseases (4) · Central Nervous System Diseases (4) · Cerebrovascular Disorders (4) · Nervous System Diseases (4) · Vascular Diseases (4) · Cardiovascular Diseases (3) · Hemorrhage (2) · Intracranial Hemorrhages (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Brain Infarction (1) · Craniocerebral Trauma (1) · Heart Diseases (1) · Infarction (1) · Ischemia (1)
PEGylated carboxyhemoglobin bovine (1) · Xenon (1) · argatroban (1) · sovateltide (1)
Pharmazz, Inc. (1) · Prolong Pharmaceuticals (1) · The University of Texas Health Science Center, Houston (1) · Turku University Hospital (1)
United States (2) · Finland (1) · India (1) · Sweden (1)
Andrew D Barreto, MD, MS (1) · Anil Gulati (1) · Michael N Dirringer, MD (1) · Rajat Dhar, MD (1) · Timo T Laitio, MD, PhD (1)
PMID 26978207, PMID 29169472, PMID 33428177, PMID 37337295
2019 (1)